Represented a private equity firm, and its affiliates, in the $4 million convertible note financing to Applied Biological Laboratories, Inc., a New York-based biotechnology company that develops, manufactures, and distributes scientifically validated natural products designed to strengthen the body’s defenses and be effective drugs for common respiratory illnesses like influenza, coronavirus and asthma.